PDGFRB and breast cancer: In a xenograft BC model, Ohno et al. efficiently administered HEK293T-derived EVs modified with the transmembrane domain of PDGFR fused to a GE11 peptide to deliver the cancer suppressor let-7a miRNA to EGFR-expressing BC tissue [238].